Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Flaxseed
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Polpharma
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Through the acquisition, Polpharma enhanced its portfolio of OTC & dermatology products, including Linomag (linseed oil), which is indicated for treating skin conditions such as eczema & intertrigo.
Product Name : Linomag
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
January 10, 2024
Lead Product(s) : Flaxseed
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Polpharma
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Flaxseed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Unilever
Deal Size : Inapplicable
Deal Type : Inapplicable
Alpha-linolenic Acid and Blood Pressure
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
September 18, 2014
Lead Product(s) : Flaxseed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Unilever
Deal Size : Inapplicable
Deal Type : Inapplicable